Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuo Nara

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Anticancer Research|October 15, 2013
NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cellsYuki Okuhashi, Mai Itoh, Nobuo Nara, et al.
Anticancer Research|April 19, 2011
Effects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cellsYuki Okuhashi, Mai Itoh, Nobuo Nara, et al.
International Journal of Molecular Medicine|October 20, 2004
The Notch ligand, Delta-1, reduces TNF-alpha-induced growth suppression and apoptosis by decreasing activation of caspases in U937 cellsMai Murata-Ohsawa, Shuji Tohda, Hanae Kogoshi, et al.
International Journal of Hematology|January 29, 2008
An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosisYuriko Morita-Hoshi, Shuji Tohda, Osamu Miura, et al.
Anticancer Research|November 28, 2008
Promotion of the self-renewal capacity of human acute leukemia cells by Wnt3ANoriko Kawaguchi-Ihara, Ikuo Murohashi, Nobuo Nara, et al.
International Journal of Molecular Medicine|February 10, 2004
The Notch ligand, Delta-1, partially inhibits GM-CSF-induced differentiation and apoptosis along with reducing the cleavage of PARP in U937 cellsMai Murata-Ohsawa, Shuji Tohda, Seiji Sakano, et al.
International Journal of Oncology|April 10, 2003
Notch ligands, Delta-1 and Delta-4 suppress the self-renewal capacity and long-term growth of two myeloblastic leukemia cell linesShuji Tohda, Mai Murata-Ohsawa, Seiji Sakano, et al.
British Journal of Haematology|April 26, 2002
A novel cell line derived from de novo acute myeloblastic leukaemia with trilineage myelodysplasia which proliferates in response to a Notch ligand, Delta-1 proteinShuji Tohda, Seiji Sakano, Mai Ohsawa, et al.
Oncology Reports|August 4, 2005
Effect of notch ligands on in vitro sensitivity to chemo-therapeutic drugs in leukemia and lymphoma cellsHanae Kogoshi, Shuji Tohda, Lu Fu, et al.
BMC Public Health|April 6, 2006
An epidemiological study on anemia among institutionalized people with intellectual and/or motor disability with special reference to its frequency, severity and predictorsHiroko Ohwada, Takeo Nakayama, Nobuo Nara, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Anticancer Research|October 15, 2013
NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cellsYuki Okuhashi, Mai Itoh, Nobuo Nara, et al.
Anticancer Research|April 19, 2011
Effects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cellsYuki Okuhashi, Mai Itoh, Nobuo Nara, et al.
International Journal of Molecular Medicine|October 20, 2004
The Notch ligand, Delta-1, reduces TNF-alpha-induced growth suppression and apoptosis by decreasing activation of caspases in U937 cellsMai Murata-Ohsawa, Shuji Tohda, Hanae Kogoshi, et al.
International Journal of Hematology|January 29, 2008
An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosisYuriko Morita-Hoshi, Shuji Tohda, Osamu Miura, et al.
Anticancer Research|November 28, 2008
Promotion of the self-renewal capacity of human acute leukemia cells by Wnt3ANoriko Kawaguchi-Ihara, Ikuo Murohashi, Nobuo Nara, et al.
International Journal of Molecular Medicine|February 10, 2004
The Notch ligand, Delta-1, partially inhibits GM-CSF-induced differentiation and apoptosis along with reducing the cleavage of PARP in U937 cellsMai Murata-Ohsawa, Shuji Tohda, Seiji Sakano, et al.
International Journal of Oncology|April 10, 2003
Notch ligands, Delta-1 and Delta-4 suppress the self-renewal capacity and long-term growth of two myeloblastic leukemia cell linesShuji Tohda, Mai Murata-Ohsawa, Seiji Sakano, et al.
British Journal of Haematology|April 26, 2002
A novel cell line derived from de novo acute myeloblastic leukaemia with trilineage myelodysplasia which proliferates in response to a Notch ligand, Delta-1 proteinShuji Tohda, Seiji Sakano, Mai Ohsawa, et al.
Oncology Reports|August 4, 2005
Effect of notch ligands on in vitro sensitivity to chemo-therapeutic drugs in leukemia and lymphoma cellsHanae Kogoshi, Shuji Tohda, Lu Fu, et al.
BMC Public Health|April 6, 2006
An epidemiological study on anemia among institutionalized people with intellectual and/or motor disability with special reference to its frequency, severity and predictorsHiroko Ohwada, Takeo Nakayama, Nobuo Nara, et al.
Pageof 4